The United States Cancer Statistics (USCS) online databases in WONDER provide cancer incidence and mortality data for the United States for the years since 1999, by year, state and metropolitan areas (MSA), age group, race, ethnicity, sex, childhood cancer classifications and cancer site. Report case counts, deaths, crude and age-adjusted incidence and death rates, and 95% confidence intervals for rates. The USCS data are the official federal statistics on cancer incidence from registries having high-quality data and cancer mortality statistics for 50 states and the District of Columbia. USCS are produced by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI), in collaboration with the North American Association of Central Cancer Registries (NAACCR). Mortality data are provided by the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Vital Statistics System (NVSS).

This publication reports on newly diagnosed cancers registered in England during 2022. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document. Cancer registration estimates are provided for: • Incidence of cancer using groupings that incorporate both the location and type of cancer by combinations of gender, age, deprivation, and stage at diagnosis (where appropriate) for England, former Government office regions, Cancer alliances and Integrated care boards • Incidence and mortality (using ICD-10 3-digit codes) by gender and age group for England, former Government office regions, Cancer alliances and Integrated care boards This publication will report on 2022 cancer registrations only, trends will not be reported as the required re-stated populations for 2012 to 2020 are not expected to be published by the Office of National Statistics (ONS) until Winter 2024.

Cancer diagnoses and age-standardised incidence rates for all types of cancer by age and sex including breast, prostate, lung and colorectal cancer.

Editor’s Choice

• Global Breast Cancer Market size is expected to be worth around USD 49.2 Bn by 2032 from USD 19.8 Bn in 2022, growing at a CAGR of 9.8% during the forecast period from 2022 to 2032.
• Breast cancer is the most common cancer among women worldwide. In 2020, there were about 2.3 million new cases of breast cancer diagnosed globally.
• Breast cancer is the leading cause of cancer-related deaths in women. In 2020, it was responsible for approximately 685,000 deaths worldwide.
• The survival rate of breast cancer has improved over the years. In the United States, the overall five-year survival rate of breast cancer is around 90%.
• The American Cancer Society recommends annual mammograms starting at age 40 for women at average risk.
• Although rare, breast cancer also occurs in men. Less than 1% of breast cancer cases are diagnosed in males.

(Source: WHO, American Cancer Society)

Number of Cancer New Cases and Registered Deaths by Ten Leading Cancer Disease Group by Sex 2022

Users can access data about cancer statistics in the United States including but not limited to searches by type of cancer and race, sex, ethnicity, age at diagnosis, and age at death. Background Surveillance Epidemiology and End Results (SEER) database’s mission is to provide information on cancer statistics to help reduce the burden of disease in the U.S. population. The SEER database is a project to the National Cancer Institute. The SEER database collects information on incidence, prevalence, and survival from specific geographic areas representing 28 percent of the United States population. User functionality Users can access a variety of reso urces. Cancer Stat Fact Sheets allow users to look at summaries of statistics by major cancer type. Cancer Statistic Reviews are available from 1975-2008 in table format. Users are also able to build their own tables and graphs using Fast Stats. The Cancer Query system provides more flexibility and a larger set of cancer statistics than F ast Stats but requires more input from the user. State Cancer Profiles include dynamic maps and graphs enabling the investigation of cancer trends at the county, state, and national levels. SEER research data files and SEER*Stat software are available to download through your Internet connection (SEER*Stat’s client-server mode) or via discs shipped directly to you. A signed data agreement form is required to access the SEER data Data Notes Data is available in different formats depending on which type of data is accessed. Some data is available in table, PDF, and html formats. Detailed information about the data is available under “Data Documentation and Variable Recodes”.

Introduction

Cancer Statistics: Cancer continues to pose a major global health challenge, ranking among the top causes of mortality and disease burden worldwide. New cancer cases are rising steadily, influenced by factors such as an aging population, changing lifestyles, and environmental factors. Reliable and current cancer data are essential for comprehending the disease's scale, shaping public health strategies, optimizing resource distribution, and driving scientific research.

These statistics provide a comprehensive overview of recent global cancer incidence, mortality, and survival trends, emphasizing prominent cancer types and geographical differences. Through this analysis, policymakers and healthcare professionals can better focus efforts on prevention, early diagnosis, and treatment to lessen Cancer's impact on communities globally.

Statistics on observed and relative survival of cancer patients (25 cancers plus for all cancers combined) in Scotland, at 1, 3, 5 and 10 years, by age and sex.

Source agency: ISD Scotland (part of NHS National Services Scotland)

Designation: National Statistics

Language: English

Alternative title: Cancer Survival

In 2025, it was estimated that there would be over 972 thousand new cancer cases among women in the United States. This statistic illustrates the estimated number of new cancer cases and deaths in the United States for 2025, by gender.

The German Centre for Cancer Registry Data (ZfKD) provides the topical cancer statistics for Germany. In an interactive database query you will get information on incidence and mortality rates as well as for prevalence and survival rates for different types of cancer.

Cancer was responsible for around *** deaths per 100,000 population in the United States in 2023. The death rate for cancer has steadily decreased since the 1990’s, but cancer still remains the second leading cause of death in the United States. The deadliest type of cancer for both men and women is cancer of the lung and bronchus which will account for an estimated ****** deaths among men alone in 2025. Probability of surviving Survival rates for cancer vary significantly depending on the type of cancer. The cancers with the highest rates of survival include cancers of the thyroid, prostate, and testis, with five-year survival rates as high as ** percent for thyroid cancer. The cancers with the lowest five-year survival rates include cancers of the pancreas, liver, and esophagus. Risk factors It is difficult to determine why one person develops cancer while another does not, but certain risk factors have been shown to increase a person’s chance of developing cancer. For example, cigarette smoking has been proven to increase the risk of developing various cancers. In fact, around ** percent of cancers of the lung, bronchus and trachea among adults aged 30 years and older can be attributed to cigarette smoking. Other modifiable risk factors for cancer include being obese, drinking alcohol, and sun exposure.

Users can download the data set and static graphs, tables and charts regarding cancers in the United States. Background The United States Cancer Statistics is web-based report created by the Centers for Disease Control and Prevention, in partnership with the National Cancer Institute (NCI) and the North American Association of Central Cancer Registries (NAACCR). The site contains cancer incidence and cancer mortality data. Specific information includes: the top ten cancers, state vs. national comparisons, selected cancers, childhood cancer, cancers grouped by state/ region, cancers gr ouped by race/ ethnicity and brain cancers by tumor type. User Functionality Users can view static graphs, tables and charts, which can be downloaded. Within childhood cancer, users can view by year and by cancer type and age group or by cancer type and racial/ ethnic group. Otherwise, users can view data by female, male or male and female. Users may also download the entire data sets directly. Data Notes The data sources for the cancer incidence data are the CD C's National Program for Cancer Registries (NPCR) and NCI's Surveillance, Epidemiology and End Result (SEER). CDC's National Vital Statistics System (NVSS) collects the data on cancer mortality. Data is available for each year between 1999 and 2007 or for 2003- 2007 combined. The site does not specify when new data becomes available.

Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

This dataset contains cancer statistics for countries members of OECD (The Organization for Economic Co-operation and Development), for OECD key partners and countries in accession negotiations with OECD. The estimated values for the two types of indicators, cancer frequency and cancer incidence, cover the years 1998, 2000, 2002, 2008 and 2012.

Background The evaluation of randomized trials for cancer screening involves special statistical considerations not found in therapeutic trials. Although some of these issues have been discussed previously, we present important recent and new methodologies.

   Methods
   Our emphasis is on simple approaches.


   Results
   We make the following recommendations:
   (1) Use death from cancer as the primary endpoint, but review death records carefully and report all causes of death
   (2) Use a simple "causal" estimate to adjust for nonattendance and contamination occurring immediately after randomization
   (3) Use a simple adaptive estimate to adjust for dilution in follow-up after the last screen


   Conclusion
   The proposed guidelines combine recent methodological work on screening endpoints and noncompliance/contamination with a new adaptive method to adjust for dilution in a study where follow-up continues after the last screen. These guidelines ensure good practice in the design and analysis of randomized trials of cancer screening.

*It is noted that multiple studies reported on more than a single cancer site and the total does not therefore equal 34.1A study reported increased risk for males but no increase for females.2A study reported increased risk for total population, but no increase when examined by gender.3A study reported increased risk for males but no increase for females.

Users can access data about cancer statistics, specifically incidence and mortality worldwide for the 27 major types of cancer. Background Cancer Mondial is maintained by the Section of Cancer Information (CIN) of International Agency for Research on Cancer by the World Health Organization. Users can access CIN databases including GLOBOCAN, CI5(Cancer Incidence in Five Continents), WHO, ACCIS(Automated Childhood Cancer Information System), ECO (European Cancer Observatory), NORDCAN and Survcan. User functionality Users can access a variety of databases. CIN Databases: GLOBOCAN provides acces s to the most recent estimates (for 2008) of the incidence of 27 major cancers and mortality from 27 major cancers worldwide. CI5 (Cancer Incidence in Five Continents) provides access to detailed information on the incidence of cancer recorded by cancer registries (regional or national) worldwide. WHO presents long time series of selected cancer mortality recorded in selected countries of the world. Collaborative projects: ACCIS (Automated Childhood Cancer Information System) provides access to data on cancer incidence and survival of children collected by European cancer registries. ECO (European Cancer Observatory) provides access to the estimates (for 2008) of the incidence of, and mortality f rom 25 major cancers in the countries of the European Union (EU-27). NORDCAN presents up-to-date long time series of cancer incidence, mortality, prevalence and survival from 40 cancers recorded by the Nordic countries. SurvCan presents cancer survival data from cancer registries in low and middle income regions of the world. Data Notes Data is available in different formats depending on which type of data is accessed. Some data is available in table, PDF, and html formats. Detailed information about the data is available.

Age standardized rate of cancer incidence, by selected sites of cancer and sex, three-year average, census metropolitan areas.

One-year and five-year net survival for adults (15-99) in England diagnosed with one of 29 common cancers, by age and sex.